The Company AAVantgarde is a clinical stage, international biotechnology company headquartered in Italy. We have developed two cutting edge AAV vector platforms to overcome DNA cargo limitations, targeting Usher syndrome type 1B and Stargardt disease. Founded by the renowned Professor…